JC Polyoma Virus DNA, Quantitative Real-Time PCR, Plasma
Use
JC Polyoma Virus DNA, Quantitative Real-Time PCR, Serum/Plasma – JC Polyoma Virus is the cause of Progressive Multifocal Leukoencephalopathy (PML), a severe demyelinating disease of the central nervous system. PML is a particular concern for individuals infected with the human immunodeficiency virus. Quantification of JC virus DNA is based upon the real-time PCR amplification and detection of JCV genomic DNA. Reportable range is 50 to 50,000,000 IU/mL (1.70 to 7.70 Log IU/mL).
Special Instructions
Not provided.
Limitations
This test has not been cleared or approved by the U.S. Food and Drug Administration. It has been validated pursuant to the CLIA regulations and is used for clinical purposes.
New York Approved
Methodology
PCR-based (RT-PCR)
Biomarkers
JC Polyoma Virus
Microorganism
LOINC Codes
- 31208-2 - Specimen source
- 101342-4 - JCPyV DNA SerPl NAA+probe-aCnc
- 101731-8 - JCPyV DNA SerPl NAA+probe-Log IU
Result Turnaround Time
3-5 days
Related Documents
For more information, please review the documents below
Specimen
Plasma
Volume
0.7 mL
Minimum Volume
0.3 mL
Container
Plastic vial
Collection Instructions
Draw blood in a lavender-top (EDTA), yellow-top (ACD-A) or white top (PPT) tube(s). Centrifuge and transfer 0.7 mL EDTA, or ACD-A or PPT plasma to a screw-cap plastic vial. Submit frozen.
Causes for Rejection
Specimens other than serum, plasma; anticoagulant other than ACD, EDTA, PPT
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 48 hours |
| Refrigerated | 7 days |
| Frozen | 30 days |